BCL2 and melanoma: Performing a quantitative analysis, Raisova et al. suggested that a Bax/Bcl-2 ratio >1.00 accelerated apoptosis in melanoma cells, whereas an imbalance in this ratio increased the metastatic potential and resistance of tumor cells to death [47].